<qa>  How many study visits will be held on the day of the open label study?In this open label study, patients will be randomly assigned to one of two arms. Group I will receive 6 mg dexamethasone daily for 10 days only. Group II will receive 6 mg dexamethasone daily for 10 days, then 8 mg dexamethasone daily for 4 weeks with a 2-week taper. Both groups will also receive albendazole and omeprazole a medicine that helps prevent gastroesophageal disease GERD, a side effect of corticosteroid use. There will be 13 study visits over a 360-day period. Blood collection will occur at most visits. Group II will also undergo sputum smears and rapid culture testing on Days 14, 28, and 42. Patients will undergo magnetic resonance imaging MRI at screening and on Day 180 and computed tomography CT scanning on Day 360. 